Melvin Gilmore, CRM is a
Peer Specialist based in Klamath Falls, Oregon. Melvin Gilmore is licensed to practice in * (Not Available) (license number ) and his current practice location is
2210 N Eldorado Ave, Klamath Falls, Oregon. He can be reached at his office (for appointments etc.) via phone at
(541) 883-1030.
NPI number for Melvin Gilmore is 1669012779 and his current mailing address is 2210 N Eldorado Ave, Klamath Falls, Oregon. He
does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1669012779.
Healthcare Provider's Profile
Full Name | Melvin Gilmore |
---|
Gender | Male |
---|
Speciality | Peer Specialist |
---|
Location | 2210 N Eldorado Ave, Klamath Falls, Oregon |
---|
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
NPI Data:
- NPI Number: 1669012779
- Provider Enumeration Date: 01/07/2020
- Last Update Date: 02/23/2021
Medical Identifiers
Medical identifiers for Melvin Gilmore such as npi, medicare ID, medicare PIN, medicaid, etc.
Identifier | Type | State | Issuer |
1669012779 | NPI | - | NPPES |
Medical Taxonomies and Licenses
Taxonomy | Type | License (State) | Status |
101YA0400X | Counselor - Addiction (substance Use Disorder) | 19-CRM-218 (Oregon) | Secondary |
175T00000X | Peer Specialist | (* (Not Available)) | Primary |
Medicare Part D Prescriber Enrollment
Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Melvin Gilmore is
NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.
Mailing Address and Practice Location
Mailing Address | Practice Location Address |
Melvin Gilmore, CRM 2210 N Eldorado Ave, Klamath Falls, OR 97601-6418 Ph: (541) 883-1030 | Melvin Gilmore, CRM 2210 N Eldorado Ave, Klamath Falls, OR 97601-6418 Ph: (541) 883-1030 |
Reviews and Comments